美国药品NDC（国家药品编码）与药品说明书数据库（U.S. FDA National Drug Code DataBase）

NDC包装代码	产品NDC	产品类型	商品名	通用名	剂型	给药途径	上市日期	结束日期	市场类别	申请号	标签持有者	活性成分	规格	包装描述
61958-2501-3	61958-2501	HUMAN PRESCRIPTION DRUG	Biktarvy	bictegravir sodium, emtricitabine, and tenofovir alafenamide fumarate	TABLET	ORAL	20210824	N/A	NDA	NDA210251	Gilead Sciences, Inc.	BICTEGRAVIR SODIUM; EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE	50 mg/1; 200 mg/1; 25 mg/1	30 TABLET in 1 BLISTER PACK (61958-2501-3)
61958-2505-1	61958-2505	HUMAN PRESCRIPTION DRUG	Biktarvy	bictegravir sodium, emtricitabine, and tenofovir alafenamide fumarate	TABLET	ORAL	20211007	N/A	NDA	NDA210251	Gilead Sciences, Inc.	BICTEGRAVIR SODIUM; EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE	30 mg/1; 120 mg/1; 15 mg/1	30 TABLET in 1 BOTTLE, PLASTIC (61958-2505-1)
50090-6247-0	50090-6247	HUMAN PRESCRIPTION DRUG	Biktarvy	bictegravir sodium, emtricitabine, and tenofovir alafenamide fumarate	TABLET	ORAL	20221128	N/A	NDA	NDA210251	A-S Medication Solutions	BICTEGRAVIR SODIUM; EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE	50 mg/1; 200 mg/1; 25 mg/1	30 TABLET in 1 BOTTLE, PLASTIC (50090-6247-0)
61958-2501-2	61958-2501	HUMAN PRESCRIPTION DRUG	Biktarvy	bictegravir sodium, emtricitabine, and tenofovir alafenamide fumarate	TABLET	ORAL	20180726	N/A	NDA	NDA210251	Gilead Sciences, Inc.	BICTEGRAVIR SODIUM; EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE	50 mg/1; 200 mg/1; 25 mg/1	7 TABLET in 1 BOTTLE, PLASTIC (61958-2501-2)
61958-2501-1	61958-2501	HUMAN PRESCRIPTION DRUG	Biktarvy	bictegravir sodium, emtricitabine, and tenofovir alafenamide fumarate	TABLET	ORAL	20180207	N/A	NDA	NDA210251	Gilead Sciences, Inc.	BICTEGRAVIR SODIUM; EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE	50 mg/1; 200 mg/1; 25 mg/1	30 TABLET in 1 BOTTLE, PLASTIC (61958-2501-1)